Literature DB >> 8271024

Surgical management of cavernous malformations of the third ventricle.

Y Katayama1, T Tsubokawa, T Maeda, T Yamamoto.   

Abstract

In order to determine adequate therapeutic approaches for cavernous malformations of the third ventricle, the authors reviewed a series of five such malformations managed at their institution and nine others reported in the literature. Four subgroups were identified in terms of the site of origin and could be characterized by different clinical manifestations: visual field defects and endocrine function deficits in patients with malformations in the suprachiasmatic region (six cases); symptoms caused by hydrocephalus in those with malformations in the foramen of Monro region (five cases); and deficits of short-term memory in those with malformations in the lateral wall (two cases) or of the floor of the third ventricle (one case). Unlike cavernous malformations at other locations, malformations of the third ventricle frequently demonstrated rapid growth (43%) and mass effects (71%). The surgical or autopsy findings suggested that the growth was attributable to repeated intralesional hemorrhages. Extralesional hemorrhage was also not uncommon, occurring in 29% of patients. Such tendencies require the adoption of a more aggressive approach to this particular group of cavernous malformations as compared to those in other locations. The risks of regrowth and extralesional hemorrhage appear to be reduced only by complete excision. The surgical approaches adopted should be aimed at providing the best access to the site where the malformation has arisen. The translamina terminalis approach for cavernous malformations in the suprachiasmatic region, the transventricular or transcallosal interfornicial approaches for those in the foramen of Monro region and the transvelum interpositum approach for those in the lateral wall or the floor of the third ventricle appear to be appropriate. In order to select the adequate surgical approach, precise diagnosis of the site of origin is crucial. In addition to neuroimaging techniques, the patient's initial symptoms provide valuable information.

Entities:  

Mesh:

Year:  1994        PMID: 8271024     DOI: 10.3171/jns.1994.80.1.0064

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

1.  Clinical features and neurosurgical treatment of trigonal cavernous malformations.

Authors:  Chengjun Wang; Meng Zhao; Xiaofeng Deng; Jia Wang; Zhongli Jiang; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2017-12-26       Impact factor: 3.042

2.  Calm the raging hormone - A new therapeutic strategy involving progesterone-signaling for hemorrhagic CCMs.

Authors:  Jun Zhang; Johnathan S Abou-Fadel
Journal:  Vessel Plus       Date:  2021-07-05

3.  Neurosurgical management of cavernous malformations located at the foramen of Monro.

Authors:  Chengjun Wang; Meng Zhao; Xiaofeng Deng; Jia Wang; Qingming Shu; Zhongli Jiang; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2017-12-04       Impact factor: 3.042

Review 4.  Cavernous hemangioma of the third ventricle: a case report and review of the literature.

Authors:  Moon-Soo Han; Kyung-Sub Moon; Kyung-Hwa Lee; Seul-Kee Kim; Shin Jung
Journal:  World J Surg Oncol       Date:  2014-07-29       Impact factor: 2.754

5.  Endoscope-assisted resection of cavernous angioma at the foramen of Monro: a case report.

Authors:  Yuji Matsumoto; Kazuhiko Kurozumi; Yousuke Shimazu; Tomotsugu Ichikawa; Isao Date
Journal:  Springerplus       Date:  2016-10-20

6.  Suprasellar and third ventricular cavernous malformation: Lessons learned in differential diagnosis and surgical planning.

Authors:  Kay O Kulason; Julia R Schneider; Ralph Rahme; Fanni Ratzon; Todd A Anderson; Deborah R Shatzkes; Christopher G Filippi; Peter D Costantino; David J Langer; John A Boockvar
Journal:  Surg Neurol Int       Date:  2017-10-13

7.  A case of a cerebral cavernous malformation of the third ventricle that caused the syndrome of inappropriate secretion of antidiuretic hormone.

Authors:  Takahiro Sasaki; Nobuhide Hayashi; Nagatsuki Tomura; Eisaku Tsuji; Hideo Okada; Toshikazu Kuwata
Journal:  Surg Neurol Int       Date:  2017-04-26

8.  Intraventricular cavernous hemangiomas located at the foramen of monro.

Authors:  Byung-Jou Lee; Chan-Young Choi; Chae-Heuck Lee
Journal:  J Korean Neurosurg Soc       Date:  2012-08-31

Review 9.  Neuropsychological features of lesion-related epilepsy in adults: an overview.

Authors:  Chris E Morrison; Luba Nakhutina
Journal:  Neuropsychol Rev       Date:  2007-10-19       Impact factor: 6.940

10.  Co-occurrence of a cerebral cavernous malformation and an orbital cavernous hemangioma in a patient with seizures and visual symptoms: Rare crossroads for vascular malformations.

Authors:  Omar Choudhri; Abdullah H Feroze; Eleonora M Lad; Jonathan W Kim; Edward D Plowey; Jason R Karamchandani; Steven D Chang
Journal:  Surg Neurol Int       Date:  2014-06-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.